Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

755
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
755
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

391
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
391
Clinical Trials01:16

Clinical Trials

6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Drug Regulation01:25

Drug Regulation

1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

212
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
212

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Hydraulic-Drive Automatic Column Chromatography System for High Precision Isotope Analysis.

Analytical chemistry·2026
Same author

Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System.

Frontiers in medicine·2025
Same author

Evaluating the reliability and quality of knee osteoarthritis educational content on TikTok and Bilibili: A cross-sectional content analysis.

Digital health·2025
Same author

Magnetocardiography-Based Ischemic Heart Disease Detection and Localization Using Machine Learning Methods.

IEEE transactions on bio-medical engineering·2018
Same author

Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.

The Journal of clinical investigation·2009
Same author

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.

Metabolism: clinical and experimental·2009

Related Experiment Video

Updated: May 16, 2025

Examination of Rapid Dopamine Dynamics with Fast Scan Cyclic Voltammetry During Intra-oral Tastant Administration in Awake Rats
10:44

Examination of Rapid Dopamine Dynamics with Fast Scan Cyclic Voltammetry During Intra-oral Tastant Administration in Awake Rats

Published on: August 12, 2015

12.6K

Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data.

Jiakuan Tu1,2, Chaoxiang Zhang1,2, Yichun Qiu1,2

  • 1The First Department of Orthopedics, Jiangxi Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Nanchang, 33003, China.

BMC Pharmacology & Toxicology
|April 1, 2025
PubMed
Summary

This study analyzed rotigotine adverse reactions using FDA data, finding product adhesion issues and unexpected serious events like falls and Parkinson's disease. Continued post-marketing surveillance is crucial for patient safety.

Keywords:
Adverse drug eventFAERSPharmacovigilanceReal-world analysisRotigotine

More Related Videos

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.0K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.6K

Related Experiment Videos

Last Updated: May 16, 2025

Examination of Rapid Dopamine Dynamics with Fast Scan Cyclic Voltammetry During Intra-oral Tastant Administration in Awake Rats
10:44

Examination of Rapid Dopamine Dynamics with Fast Scan Cyclic Voltammetry During Intra-oral Tastant Administration in Awake Rats

Published on: August 12, 2015

12.6K
Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.0K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.6K

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Neurology and Movement Disorders
  • Pharmaceutical Sciences

Background:

  • Assessing adverse reactions to rotigotine using spontaneous reports from the FDA Adverse Event Reporting System (FAERS).
  • Providing crucial insights for optimizing clinical dosing strategies for rotigotine therapy.

Purpose of the Study:

  • To evaluate the safety profile of rotigotine by analyzing spontaneous adverse event reports.
  • To identify and characterize adverse events (AEs) associated with rotigotine use.

Main Methods:

  • Retrospective analysis of FAERS data from Q2 2007 to Q2 2024.
  • Utilized four disproportionality analysis methods: Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR), Bayesian Confidence Propagation Neural Network (BCPNN), and Multinomial Gamma Poisson Shrinkage (MGPS).

Main Results:

  • Analysis of 7,570 rotigotine-related AE reports from over 17.5 million FAERS reports.
  • Identified 172 preferred terms (PTs) with significant disproportionality, including product adhesion issue (predominant AE), drug ineffectiveness, fall incidents, and Parkinson's disease.
  • Median time to AE onset was 213 days, with events occurring within 30 days and after 360 days of therapy.

Conclusions:

  • Findings align with the known safety profile of rotigotine.
  • Revealed unexpected serious adverse events, underscoring the need for ongoing monitoring.
  • Emphasizes the importance of continued vigilance in post-marketing surveillance for rotigotine.